Publications

(2024). Use of Real-World Data and Machine Learning to Screen for Maternal and Paternal Characteristics Associated with Cardiac Malformations.
(2024). Systemic Fluoroquinolone Use and Risk of Uveitis or Retinal Detachment. JAMA ophthalmology.
(2024). Quantifying possible bias in clinical and epidemiological studies with quantitative bias analysis: common approaches and limitations. bmj.
(2024). Estimated number of lives directly saved by COVID-19 vaccination programs in the WHO European Region, December 2020 to March 2023. medRxiv.
(2024). Accounting for Twins and Other Multiple Births in Perinatal Studies Conducted Using Healthcare Administration Data. medRxiv.
(2023). Impact of 2018 EU risk minimisation measures and revised pregnancy prevention programme on utilisation and prescribing trends of medicinal products containing valproate: an interrupted time series study. Drug Safety.
(2023). Association Between Fluoroquinolone Use and Hospitalization With Aortic Aneurysm or Aortic Dissection. JAMA Cardiology.
(2022). Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform. The Lancet Rheumatology.
(2022). Proton pump inhibitors and myocardial infarction: an application of active comparators in a self-controlled case series.. International journal of epidemiology.
(2022). Association between oral anticoagulants and COVID-19-related outcomes: a population-based cohort study. British Journal of General Practice.